Developing In Vivo Production of CAR T cells For the Treatment of Heart Disease: An Industry Perspective

Time: 11:00 am
day: Day Two


  • Enabling off-the-shelf immunotherapies with tight control of dosage and of activity of engineering cells
  • Exploring the applications beyond oncology to inflammation, fibrosis and inflammation-related disorders
  • Outlining Capstan’s journey and future plans to expand to the clinic